L-Alanyl-L-Glutamine

L-Alanyl-L-Glutamine

Form: Ready-to-use infusion solution

Strength: 20 g per 100 mL

Reference Brands: Dipeptiven®(EU & Global)

Category: Critical Care

L-Alanyl-L-Glutamine Infusion is a sterile dipeptide solution used in parenteral nutrition, primarily in critical care and surgical settings. It delivers a stable source of glutamine, an essential amino acid during stress, supporting immune function, gut integrity, and nitrogen transport. Commonly marketed as Dipeptiven® (20% w/v), it is administered alongside amino acid and dextrose infusions. Ideal for ICU patients with sepsis, trauma, or burns, this solution enhances recovery and reduces infection risks. Suitable for use in hospitals and nutrition therapy units, it is an essential addition to advanced clinical nutrition portfolios for pharmaceutical distributors and healthcare providers.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Glucagon

Strength: 1 mg lyophilized powder for reconstitution (IM/SC/IV)

Form: Intramuscular (IM), Subcutaneous (SC), and Intravenous (IV) injection

Reference Brands: Glucagen®, Gvoke®,Baqsimi®(US); Glucagen® Hypokit(EU)

View Details Get Enquiry
Insulin (IV)

Strength: 100 units/mL (U-100) in 10 mL vials

Form: Intravenous (IV) solution

Reference Brands: Humulin® R, Novolin® R(US); Actrapid®, Humulin® R, Insuman® Rapid(EU)

View Details Get Enquiry
Flumazenil

Strength: 0.1 mg/mL in 5 mL or 10 mL vials

Form: Intravenous (IV) injection

Reference Brands: Romazicon®(US), Anexate®(EU)

View Details Get Enquiry
Naloxone

Strength: 0.4 mg/mL in 1 mL/10 mL vials, 1 mg/mL in 2 mL prefilled syringes

Form: Intravenous (IV) injection/IM/SQ

Reference Brands: Narcan® (US); Narcan® (EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.